Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > News > Nanotechnology Investment and Commercialization Forum

September 9th, 2004

Nanotechnology Investment and Commercialization Forum

Abstract:
This forum is a networking event where Investors, Researchers and Entrepreneurs will be exposed to presentations and displays which show critical stages of the value chain of new venture creation in various nanotechnology domains.

Story:

NICF: Nanotechnology Value Chains, Focus on Biotechnology and Pharmaceutical Ventures

Nanotechnology Investment and Commercialization Forum.
The Nanotechnology Value Chain: IP to IPO.


DATE: September 29

PLACE: SRI Auditorium . 333 Ravenswood Ave. Menlo Park, CA
94025-3453

TIME: 9 a.m. registration, 10AM 6PM

MISSION: This forum is a networking event where Investors, Researchers and Entrepreneurs will be exposed to presentations and displays which show critical stages of the value chain of new venture creation in various nanotechnology domains.

Speakers will include:

  • Dr. Sam Doctors, ACET
  • Dr. Regis Kelley, UCSF, QB3 and CBE
  • Dr. Micheal Mueller, UC Discovery Grant Organization:
  • Dr. Jeff Rosner, Agilent
  • Richard Trecartin, Dorsey and Whitney LLP
  • Dr. Alexei Andreev, Draper Fisher and Jurvetson

10 AM - 5 PM:
Registration 9:00 a.m.
Morning Session 10 a.m. - 12 a.m.
12 a.m. - 1 p.m. Lunch (included)
Afternoon Session 1 p.m. - 4 p.m
Reception and Networking 4 p.m. - 5 p.m.

Register Here

About ACET

ACET, the Alameda Center for Environmental Technologies, is a business incubator helping environmental and biotech start-ups grow and prosper in the San Francisco Bay Area. ACET offers an outstanding location, expert business resources, and links to technology, expertise, and markets at home and abroad.

www.greenstart.org/acet/01acet_about.htm

About UC Discovery Grants

The Industry-University Cooperative Research Program (IUCRP) awards MICRO Grants and UC Discovery Grants in five fields of science and engineering. UC Discovery Grants form a 3-way partnership between UC, Industry Sponsors, and the State of California.

uc-industry.berkeley.edu

About QB3

During the last half-century, molecular genetics revolutionized biomedical research and gave rise to the biotechnology industry. During the next half-century, the application of the quantitative sciences - mathematics, physics, chemistry and engineering - to biomedical research brings about a second revolution that promises to improve human health and create dynamic new technologies.

To catalyze these changes, the California Institute for Quantitative Biomedical Research (QB3), a cooperative effort among three campuses of the University of California and private industry, harnesses the quantitative sciences to integrate our understanding of biological systems at all levels of complexity - from atoms and protein molecules to cells, tissues, organs and the entire organism. This long-sought integration allows scientists to attack problems that have been simply unapproachable before, setting the stage for fundamental new discoveries, new products and new technologies for the benefit of human health.

www.qb3.org

About CBE

The Center for BioEntrepreneurship has developed programs and activities that are creating the next generation of leaders in life science entrepreneurship and industry, and that weave the University community into the wider fabric of leading companies, financiers and professionals necessary for the successful migration of discoveries from the laboratory to commercialization for the benefit of the institution and society.

www.qb3.org/programs.htm

About Agilent

Agilent delivers innovative technologies, solutions and services to a wide range of customers in communications, electronics, life sciences and chemical analysis. The breadth and depth of our expertise enable us to offer solutions across our customers' entire product life cycle from research and development to manufacturing to installation and management. With insight gained from this unique and comprehensive perspective, we can help our customers get the best products and services to market quickly and profitably.

www.agilent.com

About Draper Fisher Jurvetson

Draper Fisher Jurvetson is the premier early stage venture capital firm. Founded in 1985, Draper Fisher Jurvetson has created a global network of affiliated venture funds with approximately $3 billion in capital commitments and offices in the major technology centers around the world. Headquartered in Silicon Valley, the firm has proven expertise in identifying and helping extraordinary entrepreneurs who want to change the world.

www.dfj.com

Copyright nanoSIG. Reprinted with permission.

If you have a comment, please us.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Iran to Hold 3rd Int'l Engineering Materials, Metallurgy Conference October 25th, 2014

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE